{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T21:38:12Z","timestamp":1773697092139,"version":"3.50.1"},"reference-count":36,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2010,6,16]],"date-time":"2010-06-16T00:00:00Z","timestamp":1276646400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Histopathology"],"published-print":{"date-parts":[[2010,7]]},"abstract":"<jats:p>Rossi E, Villanacci V, Bassotti G, Donato F, Festa A, Cengia G, Grisanti S &amp; Cestari R\u2028(2010) <jats:italic>Histopathology<\/jats:italic>\u2002<jats:bold>57,<\/jats:bold> 81\u201389\u2028<jats:bold>TOPOII\u03b1 and HER\u20102\/neu overexpression\/amplification in Barrett\u2019s oesophagus, dysplasia and adenocarcinoma<\/jats:bold><\/jats:p><jats:p><jats:bold>Aims:\u2002<\/jats:bold> Topoisomerase II\u03b1 (<jats:italic>TOPOII\u03b1<\/jats:italic>) and <jats:italic>HER\u20102\/neu<\/jats:italic> are chromosome 17q genes coamplified in various cancers; no data exist for Barrett\u2019s oesophagus (BO) and BO adenocarcinoma (ADC). The aim was to investigate gene amplification and protein overexpression of TopoII\u03b1 and Her\u20102\/neu in non\u2010dysplastic BO, dysplastic BO, Barrett ADC, and chromosome 17 aneusomy.<\/jats:p><jats:p><jats:bold>Methods and results:\u2002<\/jats:bold> Forty\u2010four patients [18 BO, 13 BO with dysplasia (five low\u2010grade dysplasia, eight high\u2010grade dysplasia) and 13 ADC in BO] were evaluated by immunohistochemistry and fluorescence <jats:italic>in situ<\/jats:italic> hybridization (FISH). Genes (<jats:italic>HER\u20102\/neu<\/jats:italic> and <jats:italic>TOPOII\u03b1<\/jats:italic>) and chromosome 17 were evaluated by FISH. Patients with BO, dysplasia and ADC were compared. A significant association was found between TOPOII\u03b1 protein overexpression and <jats:italic>TopoII\u03b1<\/jats:italic> gene amplification, chromosome 17 aneusomy, <jats:italic>HER\u20102\/neu<\/jats:italic> gene amplification and HER\u20102 protein overexpression as well as between HER\u20102 protein and <jats:italic>HER\u20102\/neu<\/jats:italic> gene, <jats:italic>TopoII\u03b1<\/jats:italic> gene and aneusomy for chromosome17, and between the genes <jats:italic>TOPOII\u03b1<\/jats:italic> and <jats:italic>HER\u20102\/neu<\/jats:italic>. Gene amplification (<jats:italic>HER\u20102\/neu<\/jats:italic>, <jats:italic>TOPOII\u03b1<\/jats:italic>), protein overexpression (HER\u20102\/TOPOII\u03b1), and chromosome 17 aneusomy were associated with dysplasia or ADC. Most BO patients showed no amplification\/overexpression\/aneusomy for the above genes, proteins and chromosome, with no differences between dysplasia and ADC.<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold> HER\u20102\/neu and TOPOII\u03b1 amplification\/overexpression might discriminate between BO and dysplasia\/ADC. Chromosome 17 aneusomy is associated with dysplasia or ADC in BO.<\/jats:p>","DOI":"10.1111\/j.1365-2559.2010.03580.x","type":"journal-article","created":{"date-parts":[[2010,6,16]],"date-time":"2010-06-16T09:13:35Z","timestamp":1276679615000},"page":"81-89","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["TOPOII\u03b1 and HER\u20102\/neu overexpression\/amplification in Barrett\u2019s oesophagus, dysplasia and adenocarcinoma"],"prefix":"10.1111","volume":"57","author":[{"given":"Elisa","family":"Rossi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Villanacci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabrio","family":"Bassotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Donato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Festa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianpaolo","family":"Cengia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Grisanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renzo","family":"Cestari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,7,9]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-2962"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1309\/P3CHDX9LY6H2LY0G"},{"key":"e_1_2_7_4_2","first-page":"393","article-title":"Analysis of ERBB2 and TOP2A gene status using fluorescence in situ hybridization versus immunohistochemistry in localized breast cancer","volume":"53","author":"Bouchalov\u00e1 K","year":"2006","journal-title":"Neoplasma"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2006.05.008"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2006.038281"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/stem.160413"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(00)80195-1"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001813-199504000-00002"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64952-8"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/92.24.1991"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/90.18.1346"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(97)90256-2"},{"key":"e_1_2_7_14_2","first-page":"1107","article-title":"HER\u20102 amplification and topoisomerase IIalpha gene aberrations as predictive markers in node\u2010positive breast cancer patients randomly treated either with an anthracycline\u2010based therapy or with cyclophosphamide, methotrexate, and 5\u2010fluorouracil","volume":"8","author":"Di Leo A","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"e_1_2_7_15_2","first-page":"1061","article-title":"Amplification and overexpression of topoisomerase IIalpha predict response to anthracycline\u2010based therapy in locally advanced breast cancer","volume":"8","author":"Coon JS","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.20008"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2004.06.021"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1245\/ASO.2005.12.025"},{"key":"e_1_2_7_19_2","volume-title":"WHO pathology and genetics: tumors of digestive system","author":"Hamilton SR","year":"2000"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2007.01.011"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2007.07.009"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.53.12.890"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3800774"},{"key":"e_1_2_7_24_2","first-page":"3857","article-title":"Microvessel density, expression of estrogen receptor alpha, MIB\u20101, p53, and c\u2010erbB\u20102 in inflammatory breast cancer","volume":"8","author":"McCarthy NJ","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"e_1_2_7_25_2","first-page":"193","article-title":"Evaluation of angiogenesis, p\u201053 tissue protein expression and serum VEGF in patients with endometrial cancer","volume":"51","author":"Mazurek A","year":"2004","journal-title":"Neoplasma"},{"key":"e_1_2_7_26_2","first-page":"761","article-title":"Amplification of the c\u2010erbB\u20102 (HER\u20102\/neu) gene in gastric cancer cells. Detection by fluorescence in situ hybridization","volume":"151","author":"Ishikawa T","year":"1997","journal-title":"Am. J. Pathol."},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1155\/2000\/947249"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2003.007724"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.2870020112"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2005.01.016"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-0302"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-0465"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1582-4934.2008.00517.x"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1166"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.3322\/canjclin.56.2.69"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1526-8209(11)70623-1"},{"key":"e_1_2_7_37_2","first-page":"347","article-title":"Targeted therapy with trastuzumab in dysplasia and adenocarcinoma arising in Barrett\u2019s esophagus: a translational approach","volume":"54","author":"Villanacci V","year":"2008","journal-title":"Minerva Gastroenterol. Dietol."}],"container-title":["Histopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2559.2010.03580.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2559.2010.03580.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T22:46:48Z","timestamp":1697323608000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2559.2010.03580.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["10.1111\/j.1365-2559.2010.03580.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2559.2010.03580.x","archive":["Portico"],"relation":{},"ISSN":["0309-0167","1365-2559"],"issn-type":[{"value":"0309-0167","type":"print"},{"value":"1365-2559","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7]]},"assertion":[{"value":"2010-07-09","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}